Tema ETF Trust Tema GLP-1, Obesity & Cardiometabolic ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRTS and other ETFs, options, and stocks.

About HRTS

HRTS is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. 

Index-Tracked
Index-Tracked
Category
Health
CategoryHealth
Number of holdings
47
Number of holdings47
Inception Date
Nov 20, 2023
Inception DateNov 20, 2023

What's in this fund

Sectors

As of September 4, 2024
Healthcare100.00%

Top 10 Holdings (44.75% of total assets)

As of September 4, 2024
NameSymbol% Assets
AmgenAMGN7.16%
Eli LillyLLY5.54%
Alnylam PharmaceuticalsALNY5.21%
BridgeBio PharmaBBIO4.57%
Vertex PharmaceuticalsVRTX4.37%
Novo Nordisk A/S Class BNOVO B (XCSE)4.36%
Chugai Pharmaceutical Co Ltd4519 (XTKS)3.64%
Ultragenyx PharmaceuticalRARE3.50%
CytokineticsCYTK3.25%
AstraZeneca PLCAZN (XLON)3.15%

HRTS Key Statistics

AUM
84.17M
AUM84.17M
Price-Earnings ratio
-27.60
Price-Earnings ratio-27.60
30-Day yield
-0.18
30-Day yield-0.18
Average volume
15.97K
Average volume15.97K
High today
—
High today—
Low today
—
Low today—
Open price
$34.43
Open price$34.43
Volume
0.00
Volume0.00
52 Week high
$36.03
52 Week high$36.03
52 Week low
$26.26
52 Week low$26.26
Expense ratio
0.99
Expense ratio0.99
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.